Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mirza Rahman"'
Autor:
Alvin Estilo, LaRee Tracy, Carol Matthews, Michele Riggen, Annette Stemhagen, Timothy Wilt, Anatoliy Krakovich, Charlotte Jones-Burton, Vinu George, Robert McQuade, Mirza Rahman
Publikováno v:
Clinical Kidney Journal. 15:1553-1561
Background On approval of JYNARQUE (tolvaptan) for use in patients with autosomal dominant polycystic kidney disease (ADPKD) at risk for rapid progression, the US Food and Drug Administration required a Risk Evaluation and Mitigation Strategy (REMS)
Publikováno v:
Advances in Therapy
Introduction Hyponatremia is a common condition of varying etiology among hospitalized patients and is associated with adverse outcomes. Treatment to normalize serum sodium is advisable. Tolvaptan received European Union marketing authorization for h
Autor:
Sreedhar Kollem, Mirza Rahman Baig, Donthireddy Lasya, Eligeti Ashwad Kalyan, Karre Nithin Varma
Publikováno v:
2022 2nd International Conference on Intelligent Technologies (CONIT).
Publikováno v:
Pharmaceutical medicine. 35(5)
A Development Safety Update Report (DSUR) is a comprehensive review of safety information collected during an annual reporting period for an investigational drug. The creation of a DSUR is a resource-intensive process, requiring effective communicati
Autor:
Liliam Pineda Salgado, Mirza Rahman, Michael Jan, Ritu Gupta, Vinu George, Alvin Estilo, Osman Turkoglu
Publikováno v:
Advances in Therapy
Introduction Drug-induced liver injury (DILI) is the most frequent cause of acute liver failure in North America and Europe, but it is often missed because of unstandardized diagnostic methods and criteria. This study aimed to develop and validate an
Autor:
Timothy Peters-Strickland, Antonia Coppin-Renz, Uli Geis, Mirza Rahman, Wally Landsberg, Imad Al-Dakkak, Emiel van Heumen
Publikováno v:
Drug Safety
Introduction Two risk minimization (RM) tools—a healthcare professional frequently asked questions (HCP-FAQs) brochure and a patient/caregiver information brochure (PCIB)—were developed for HCPs and for adolescents (aged ≥ 13 years) receiving a
Autor:
Kavita V. Nair, Ahmad Naim, Mirza Rahman, Vicki Zhang, Jill Van Den Bos, B Tang, Joseph J. Saseen
Publikováno v:
Current medical research and opinion. 25(2)
To evaluate how changes in infliximab dose influence resource utilization and expenditures for patients with rheumatoid arthritis (RA).A retrospective analysis using claims from January 1, 1999 through March 31, 2005 in the MedStat MarketScan databas